Animal models in type 2 diabetes research: an overview.

Department of Pharmacology & Toxicology, National Institute of Pharmaceutical Education & Research, Mohali, India.
The Indian Journal of Medical Research (Impact Factor: 2.06). 04/2007; 125(3):451-72.
Source: PubMed

ABSTRACT Type 2 diabetes is a complex and heterogeneous disorder presently affecting more than 100 million people worldwide and causing serious socio-economic problems. Appropriate experimental models are essential tools for understanding the pathogenesis, complications, and genetic or environmental influences that increase the risks of type 2 diabetes and testing of various therapeutic agents. The animal models of type 2 diabetes can be obtained either spontaneously or induced by chemicals or dietary or surgical manipulations and/or by combination thereof. In recent years, large number of new genetically modified animal models including transgenic, generalized knock-out and tissue-specific knockout mice have been engineered for the study of diabetes. This review gives an overview on the animal models of type 2 diabetes with reference to their origin/source, characteristic features, underlying causes/mechanism(s), advantages and disadvantages to the investigators in diabetes research. In addition, it especially describes the appropriate selection and usefulness of different animal models in preclinical testing of various new chemical entities (NCEs) for the treatment of type 2 diabetes.

1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity and type 2 diabetes mellitus (T2DM) are rapidly growing worldwide epidemics. It is accepted that interactions between obesity, insulin resistance, and β-cell dysfunction cause T2D, but the mechanisms regulating the interplay among these impairments remain unclear. Rodent models of high-fat diet (HFD)-induced obesity are used widely to study human diabesity. However, even with 9000+ rodent-based HFD publications on PubMed over the last decade, the mechanistic and therapeutic correlation to human diabesity has remained low. We investigated the reasons for this translational discrepancy by conducting a comprehensive review of HFD models. It appears that HFD models have limited translatable benefit due—at least in part—to divergent dietary compositions/protocols, species/strain variability, and inconsistent disease penetrance, severity, & duration. Combining HFD with other T2D induction modes exacerbates this species barrier—mechanistic insights from these studies are often confined to rodents, rather than being applicable to humans. Therefore, future research dedicated to acquiring transnationally relevant data would accelerate our understanding and development of therapeutics for human diabesity.
    Experimental Biology 2014; 04/2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To collect and document information on anti-diabetic plants traditionally used in the treating of diabetes in Urmia at Northwest Iran because ethnomedicines are considered as valuable sources to find new potential drugs. Methods: We used the method of direct observation and interview (35 traditional healers) along with gathering herbarium specimens mentioned plants in site. Results: There were 30 medicinal plants from 17 families for the treatment of diabetes. The family with most plants was Lamiaceae (20%). Leaves (20%) are often used and its form is decoction (70%). It was also found that Citrullus colocynthis has the most frequency of use among traditional healers. Conclusions: Furthermore, base on current findings many of the mentioned plants have potential active ingredients to influence diabetes.
    Asian Pacific Journal of Tropical Medicine 10/2014; 7:348-354. · 0.50 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A relationship between obesity and type 2 diabetes is now generally well accepted. This relationship represents several major health hazards including morbid obesity and cardiovascular complications worldwide. Diabetes mellitus is a complex metabolic disorder characterized by impaired insulin release and insulin resistance. Lipids play an important physiological role in skeletal muscle, heart, liver and pancreas. Deregulation of fatty acid metabolism is the main culprit for developing insulin resistance and type 2 diabetes. A predominant predisposing factor to developing obesity, insulin resistance and type 2 diabetes is the permanent elevation of free fatty acids in plasma followed by impaired utilization of lipids by muscle. Diabetes-induced inflammation and oxidative stress have also vital role for development of insulin resistance in diabetic patients. The present review is intended to describe the correlation between lipids, obesity and insulin resistance based on current literature, in order to elucidate involved molecular mechanisms in depth.
    Lipid Insights 01/2013; 6:1-11.

Full-text (2 Sources)

Available from
May 15, 2014